Best Agrolife Ltd. · NSE:BESTAGRO
Best Agrolife — Q3 FY26 Earnings Presentation
19 slides from Best Agrolife's earnings presentation, Feb 9, 2026
Slide 1: Exchange filing letter for corporate presentation
Affrotiielimited CIN : L74l lODL1992PLCT16773 WBest 9th February,2026 To BSE Limited Limited National Stock Exchange of India 25th Floor, P.J. Towers, Exchange Plaza, C-1, Block-G' Dalal Street, Mumbai-400001 Bandra - Kurla ComPlex Bandra (E), Mumbai-400051 ffitr tD' nnsr.lcRo Dear Sir/ Madam. Discl
Slide 2: Q3 FY25-26
A Folife Liat ‘i » = =
Slide 3: Disclaimer
Disclaimer The Presentation is to provide the general background information about the company’s activities as at the date of the presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation that any i
Slide 4: Table of Contents
Table of Contents Company Snapshot Management Comment Performance Highlights Way Ahead
Slide 5: Company Snapshot
Company Snapshot 15th 40 9 10,000+ Largest Indian Warehouses Patented Dealers Agrochemical 21 States Products Company* 4 530+ 800+ 14% Manufacturing units Formulations Employees 3 Year Revenue 7000 MTPA Technical Registrations CAGR 35500 KL Formulation *Agropages Top 20 Indian Agrochemical Companies
Slide 6: Management Comment
Management Comment “During Q3 FY26, our sales performance was comparatively lower on a year-on-year basis, largely due to a combination of climatic and market-related factors beyond our control. October 2025 witnessed exceptionally high rainfall across India, with the country recording 112.2 mm, whi
Slide 7: Patented Products
Patented Products RONFENTM TRICOLORTM NEMAGENTM SHOT DOWNTM WARDEN EXTRATM Insecticide (SC) Fungicide (SC) Insecticide (SC) Herbicide (ME) Insecticide + Fungicide (FS) Pyriproxyfen - 8% Trifloxystrobin - 10% Chlorantraniliprole - 4.5% Haloxyfop-R Methyl - 12.8% Trifloxystrobin - 6% Dinotefuran - 5%
Slide 8: Q3 & 9M FY26 Performance
Q3 & 9M FY26 Performance Q3 FY26 Performance • Revenue from Operations: The company reported revenue from operations of ₹202.9 crore in Q3 FY26, compared to ₹274.1 crore in Q3 FY25, impacted by erratic and unseasonal rainfall across key agricultural regions. • Gross Margin: Gross margin remained sta
Slide 9: Operational & Business Highlights
Operational & Business Highlights Operational Highlights • Brand sales constituted 59% of Q3 FY26 revenues and 66% of 9M FY26 revenues, indicating a strong branded portfolio focus. • Patented Products Performance: • Patented products contributed 43% of brand sales in 9M FY26, up from 29% in 9M FY25.
Slide 10: Financial Highlights
Financial Highlights Revenue From Operations EBITDA* (₹ Crore) (₹ Crore) 3.8 -5.8 274 202.9 Q3 FY25 Q3 FY26 Q3 FY25 Q3 FY26 PAT EPS Q3 FY25 Q3 FY26 Q3 FY25 Q3 FY26 (₹ Crore) (₹ Crore) -0.68 -0.36 -24 -12.7 *EBITDA is calculated excluding other income
Slide 11: Building a Branded Business
Building a Branded Business Branded v/s Institutional Sales Contribution of Patented products in Branded Sales 28% 34% 57% 71% 72% 66% 43% 29% 9M FY25 9M FY26 9M FY25 9M FY26 Branded Institutional Sales Patented Non-Patented
Slide 12: Consolidated P&L for Q3 FY26
Consolidated P&L for Q3 FY26 Value (INR Cr) Q3 FY26 Q3 FY25 YoY 9M FY26 9M FY25 Revenue from Operations 202.9 274.1 -26% 1101 1540 Gross Margin 65 89 -27% 345 468.4 EBITDA* 3.8 -5.8 165% 127 196 EBITDA Margin (%) 1.9% -2.1% 396.89 Bps 11.5% 12.7% Profit After Tax -12.7 -24.2 47.3% 46 91.8 PAT Margin
Slide 13: Consolidated P&L for Q3 FY26
Consolidated P&L for Q3 FY26 Value (INR Cr) Q3 FY26 Q3 FY25 YoY Q2 FY26 Revenue from Operations 202.9 274.1 -26% 516.8 Other Income 1.3 -0.1 -2 Total Revenue 204.2 274.1 -25.5% 515 Cost of Goods Sold 138 185.1 347 Employee Benefits Expense 25.5 28.8 24 Other Operating Expenses 35.7 66 68 Total Expen
Slide 14: Consolidated P&L for 9M FY26
Consolidated P&L for 9M FY26 Value (INR Cr) 9M FY26 9M FY25 FY25 Revenue from Operations 1101 1540 1814 Other Income 3.5 4 5 Total Revenue 1104.5 1544 1819 Cost of Goods Sold 756 1071.6 1283 Employee Benefits Expense 74 84 107 Other Operating Expenses 144 188.5 224 Total Expenses 974 1344.1 1614 EBI
Slide 15: Key Ratios
Key Ratios Debt to Equity (x) Net Debt to Equity (x) 1.06 0.89 0.90 0.97 0.62 0.56 0.48 0.47 FY23 FY24 FY25 9M FY26 FY23 FY24 FY25 9M FY26 Current Ratio (x) ROCE 1.56 26% 1.35 1.37 15% 13% 1.21 8% FY23 FY24 FY25 9M FY26 FY23 FY24 FY25 9M FY26 (Not Annualized) *Formulae: ROCE= EBIT/ Capital Employed*
Slide 16: Working Capital Movement
Working Capital Movement 243 243 218 220 217 212 188 178 173 165 166 156 FY24 FY25 9M FY25 9M FY26 Inventory Days Cash Coversion Days Working Capital Days
Slide 17: Inventory and AR
Inventory and AR Inventory Accounts Receivables 958 873 812 770 773 783 744 666 645 618 589 564 Sep-24 Dec-24 Mar-25 Jun-25 Sep-25 Dec-25 Sep-24 Dec-24 Mar-25 Jun-25 Sep-25 Dec-25
Slide 18: Experienced Management Team
Experienced Management Team Mr. Vimal Alawadhi Mr. P. N. Karlekar Mr. N Surendra Sai Mr. Vikas Jain Managing Director Director Director Chief Financial Officer A t rue visionary and a pa ssionat e A chemical Engineer from UDCT- one of A pass ionate t echnolo gist and A seasoned finance professional
Slide 19: Thank You
Thank You Contact Us: ir@bestagrolife.com (Investor Relations) DISCLAIMER This presentation includes certain forward looking statements and information including statements concerning the outlook for business. The statements are based on certain expectations, assumptions, anticipated developments an